Mesoblast Limited
MESO · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,386,651 | $1,589,110 | $2,259,746 | $932,430 |
| - Cash | $161,158 | $161,551 | $38,029 | $38,029 |
| + Debt | $128,157 | $128,157 | $126,111 | $126,111 |
| Enterprise Value | $1,353,650 | $1,555,716 | $2,347,828 | $1,020,512 |
| Revenue | $7,021 | $7,021 | $1,578 | $1,578 |
| % Growth | 0% | 344.9% | 0% | – |
| Gross Profit | -$16,227 | -$16,227 | -$1,702 | -$1,702 |
| % Margin | -231.1% | -231.1% | -107.8% | -107.8% |
| EBITDA | -$19,637 | -$19,637 | -$9,455 | -$9,455 |
| % Margin | -279.7% | -279.7% | -599.1% | -599.1% |
| Net Income | -$27,104 | -$27,104 | -$23,967 | -$23,967 |
| % Margin | -386% | -386% | -1,518.8% | -1,518.8% |
| EPS Diluted | -0.21 | -0.21 | -0.21 | -0.21 |
| % Growth | 0% | 0% | 0% | – |
| Operating Cash Flow | -$14,650 | -$12,683 | -$10,328 | -$10,328 |
| Capital Expenditures | -$287 | -$125 | -$53 | -$53 |
| Free Cash Flow | -$14,937 | -$12,808 | -$10,381 | -$10,566 |